Efficiency and safety of Conbercept intravitreal injection combined with posterior sub-tenon injection of triamcinolone acetonide in macular edema due to central retinal vein occlusion

开始日期2019-02-01

申办/合作机构

中日友好医院

ChiCTR-INR-17011877 / RecruitingIIT

Clinical trial of Intravitreal Anti-VEGF Combined with Dexamethasone for Central Retina Vein Occlusion with Macular Edema

开始日期2017-07-01

申办/合作机构-

100 项与缺血型视网膜中央静脉阻塞相关的临床结果

登录后查看更多信息

100 项与缺血型视网膜中央静脉阻塞相关的转化医学

登录后查看更多信息

0 项与缺血型视网膜中央静脉阻塞相关的专利（医药）

登录后查看更多信息

388

项与缺血型视网膜中央静脉阻塞相关的文献（医药）

2024-09-01·Journal of Neuro-Ophthalmology

Papilledema and Combined Central Retinal Artery and Central Retinal Vein Occlusion as a Manifestation of Behçet Disease.

Letter

作者: Maheswaranathan, Mithu ; Schuman, Stefanie G ; Sengupta, Sweta ; Peters, Katherine S ; Gospe, Sidney M

2024-08-05·Cureus

Ischemic Central Retinal Vein Occlusion Accompanied by Macular Edema: A Case Report

Article

作者: Daigavane, Sachin ; Pawar, Yuga ; Thool, Archana R ; Javed, Zoya ; Swaminathan, Uma

One of the primary reasons for discernible or complete loss of sight in middle-aged and older persons is central retinal vein occlusion (CRVO). Three intravitreal bevacizumab (Avastin) injections were administered to a 39-year-old male patient as part of his therapy for his prior diabetic retinopathy due to uncontrolled diabetes. The patient was advised to undergo gonioscopy and an undilated iris examination to look for angle neovascularization during the next three months of follow-up. We demonstrated an extraordinary instance of unilateral ischemia CRVO (macular edema), where the main cause of risk was insulin resistance. To avoid a situation like this, close observation and diabetes management are recommended.

2024-08-01·BMJ Open Ophthalmology

Oscillatory potential findings in patients with acute ischaemic central retinal vein occlusion

Article

作者: Qu, Ya ; Li, Shiying ; Ran, Li ; Wang, Gang ; Wang, Min

AimsTo explore the sensitive components of full-field electroretinography (ERG) as indicators of retina function at the onset of acute ischaemic central retinal vein occlusion (CRVO).Methods11 patients (11 eyes) with ischaemic CRVO and 32 patients (32 eyes) with non-ischaemic CRVO who presented with first-episode unilateral CRVO within 1 month of symptom onset and with no previous intervention were examined by the International Society for Clinical Electrophysiology of Vision standard ERG.ResultsA significant amplitude decline and peak time delay in light-adapted (LA) 3 ERG and LA 30 Hz flicker ERG (p<0.05 for all) was found in the ischaemic CRVO eyes, compared with the non-ischaemic CRVO eyes. The b/a amplitude ratio of dark-adapted (DA) 3 ERG, DA 10 ERG and LA 3 ERG was significantly different between the ischaemic and non-ischaemic groups (p<0.05 for all). Regarding oscillatory potentials (OPs), the amplitudes of OP1, OP2 and OP3 as well as the sum of DA 3 OP1–4 amplitudes (∑OPs) showed significant changes (p<0.01 for all) between two groups. No peak time delay of OPs was found between the ischaemic and non-ischaemic CRVO eyes.ConclusionThe amplitude of DA 0.01 ERG, components of LA 3 ERG and LA 30 Hz flicker ERG, and the b/a amplitude ratio could be among the most sensitive indicators in patients with acute ischaemic CRVO. The amplitudes of OP1, OP2, OP3 and ∑OPs in the CRVO eyes were reduced to 40% of the control values, showing that this quantitative method is reliable for detecting ischaemic retinal diseases, even in early stage.